Stockreport

Soleno: Mid-2024 NDA Filing For PWS Treatment Is A Major Catalyst To Watch [Seeking Alpha]

Soleno Therapeutics, Inc.  (SLNO) 
Last soleno therapeutics, inc. earnings: 5/13 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.soleno.life/investor-overview
PDF Ability to file NDA of DCCR for PWS was because of statistical significance achieved based on the primary endpoint of Study C602, which was the HQ-CT score. The globa [Read more]